Account Wins & Losses
Agency networks such as BBDO, Saatchi & Saatchi, and FCB reported key pharma account wins in August, according to R3.
For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson & Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.
Publicis Healthcare Communications Group named Anders Ekman managing director of Saatchi & Saatchi Health Communications New York, the flagship professional healthcare agency of the Saatchi brand.
Pfizer awarded Ketchum a global assignment for Lipitor as the pharmaceutical company prepares for its top-selling drug to go off patent at the end of this year.
Interpublic Group's ICC will handle professional advertising for GlaxoSmithKline over-the-counter cold sore cream Abreva after winning the account this month.
Merck will consolidate media duties on all of its brands, including the newly acquired Schering-Plough portfolio, after a review.
Bayer announced today that it will split global advertising duties between Omnicom and WPP, a consolidation process set to be completed over the next two years.
Cephalon has consolidated its oncology advertising business into Interpublic Group's Draftfcb.
Pfizer has given McCann HumanCare the heave-ho on its Viagra consumer account, awarding the business instead to Dentsu's McGarryBowen.
McCann Worldgroup is launching a health and wellness experiential marketing practice under the umbrella of its Momentum network.
Pfizer passed Chantix creative work to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug, agency sources confirmed.
One of medical advertising's oldest shops - KPR, founded in 1962 - will cease to operate as an independent agency, having lost most of its business in the Johnson & Johnson advertising consolidation.
Johnson & Johnson is considering consolidating advertising and marketing for its pharmaceutical brands into one or two companies, a company spokesperson told MM&M.
Schering-Plough awarded media duties in the US to MediaVest, a subsidiary of Publicis Groupe.
Seidler Bernstein won a branding and marketing assignment from venture-backed medical device company OmniSonics Medical Technologies to develop and implement a full branding initiative, behind the devicemaker's OmniWave product.
Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.
MedThink Communications has been retained by Salix Pharmaceuticals to launch and promote its newest product under development, an orally disintegrating form of metoclopramide.
OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, has selected Stratagem Healthcare Communications to handle the company's marketing and branding initiatives for Renova (tretinoin cream 0.02%) indicated to reduce fine facial lines associated with chronic sun exposure when used as part of a comprehensive skin care program.
Allergan awarded Pacific Communications the DTC assignment for its severe axillary hyperhidrosis (severe underarm sweating) indication on Botox following a competitive pitch.
Shire Pharmaceuticals tapped InVentiv's Palio to handle professional advertising and promotion for Fosrenol, which is indicated for hyperphosphatemia in patients with end stage renal disease.
GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said.
Griff/SMC, has been chosen as agency of record by Med-Aesthetic Solutions, a Cardiff, CA,-based provider of practice building services and technologies used in aesthetic medicine.
Lazur Hoyvald Goldstein Partners has been chosen agency of record by Medical Resources, Inc. to provide branding and marketing services for the corporation's network of fixed-site outpatient medical diagnostic imaging centers.
MedAccess, a division of Access Communications, has been named agency of record for Stiefel Laboratories, brought on board to help with the launch of skin-care products, Extina and RevalèSkin.
Physician-focused agency Adient has been closed, with staff and accounts, including Ortho-McNeil business, shifted to other units within WPP's CommonHealth family.
GSW Worldwide, an inVentiv Health company, has been named agency of record by BioBehavioral Diagnostics Company for their McLean Motion and Attention Test, a non-invasive, diagnostic system that provides evidence-based measures of the core symptoms of attention deficit hyperactivity disorder.
Draftfcb Healthcare has been awarded professional agency of record status for Alpharma's Flector Patch, the first prescription topical NSAID.
Pacific Communications has been chosen as the agency of record for Prometheus Laboratories, a San Diego, CA-based company that focuses on the diagnosis and treatment of gastrointestinal, autoimmune, and inflammatory diseases and disorders.
Galderma Laboratories has awarded agency of record for advertising and promotion for three products in the corrective and aesthetic market to Brand Pharm, a member of the Publicis Healthcare Communications Group of agencies.
Centron has announced the following new agency of record assignments.
- The 2017 pipeline report: What to know about next year's launches
- Five things for pharma marketers to know: Monday, November 28, 2016
- Lilly's branded app for Trulicity looks to address adherence
- Lawmakers cut CME exemption from 21st Century Cures Act
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Prescription drug spending rises 9% in 2015, to $324 billion
- As users move to mobile, Google says they made 200 million queries for info about cancer drugs
- Five things for pharma marketers to know: Friday, December 2, 2016
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Thursday, December 1, 2016